Trevena Inc (NASDAQ: TRVN) biopharmaceutical company announced that it had made it to the small-cap Russell 2000® Index, the broad-market Russell 3000® Index, and the Russell Microcap® Index. The respective biopharmaceutical company is involved in creating and commercialization of drugs for individuals suffering from central nervous system (CNS) disorders.  CEO […]